AU2095099A - Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists - Google Patents

Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists

Info

Publication number
AU2095099A
AU2095099A AU20950/99A AU2095099A AU2095099A AU 2095099 A AU2095099 A AU 2095099A AU 20950/99 A AU20950/99 A AU 20950/99A AU 2095099 A AU2095099 A AU 2095099A AU 2095099 A AU2095099 A AU 2095099A
Authority
AU
Australia
Prior art keywords
preparationand
phthalimide
ant
pyrrolidine
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20950/99A
Inventor
Anura Dantanarayana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU2095099A publication Critical patent/AU2095099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20950/99A 1997-12-23 1998-12-22 Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists Abandoned AU2095099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6862797P 1997-12-23 1997-12-23
US60068627 1997-12-23
PCT/US1998/027585 WO1999032479A1 (en) 1997-12-23 1998-12-22 Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparation and their use as muscarinic receptor (ant-)agonists

Publications (1)

Publication Number Publication Date
AU2095099A true AU2095099A (en) 1999-07-12

Family

ID=22083741

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20950/99A Abandoned AU2095099A (en) 1997-12-23 1998-12-22 Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists

Country Status (2)

Country Link
AU (1) AU2095099A (en)
WO (1) WO1999032479A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030892A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
PL2516434T3 (en) 2009-12-23 2015-11-30 Takeda Pharmaceuticals Co Fused heteroaromatic pyrrolidinones as syk inhibitors
US9056873B2 (en) 2011-06-22 2015-06-16 Takeda Pharmaceutical Company Limited Substituted 6-aza-isoindolin-1-one derivatives
PL2780015T3 (en) 2011-11-18 2017-06-30 Heptares Therapeutics Limited Muscarinic m1 receptor agonists
SG11201501620QA (en) 2012-09-18 2015-04-29 Heptares Therapeutics Ltd Bicyclic aza compounds as muscarinic m1 receptor agonists
GB2519470A (en) * 2013-09-18 2015-04-22 Heptares Therapeutics Ltd Bicyclic aza compounds as muscarinic M1 receptor agonists
GB201404922D0 (en) 2014-03-19 2014-04-30 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201617454D0 (en) 2016-10-14 2016-11-30 Heptares Therapeutics Limited Pharmaceutical compounds
GB201810239D0 (en) 2018-06-22 2018-08-08 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819960D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
WO2020205867A1 (en) 2019-04-02 2020-10-08 Aligos Therapeutics, Inc. Compounds targeting prmt5
GB202020191D0 (en) 2020-12-18 2021-02-03 Heptares Therapeutics Ltd Pharmaceutical compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3316276A (en) * 1965-10-06 1967-04-25 Robins Co Inc A H N-(3-pyrrolidinyl)-phthalimide derivatives
GB1486104A (en) * 1975-01-23 1977-09-21 Wyeth John & Brother Ltd Phthalimidopiperidine derivatives
WO1996013262A1 (en) * 1994-10-27 1996-05-09 Merck & Co., Inc. Muscarine antagonists
WO1997016192A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Muscarine antagonists
WO1997016186A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Muscarine agonists

Also Published As

Publication number Publication date
WO1999032479A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU5203999A (en) Beta3-adrenergic receptor agonists
AU5640299A (en) 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
AU5640199A (en) 4-quinolinemethanol derivatives as purine receptor antagonists (i)
HK1044952A1 (en) N-pyrazole A2A receptor agonists n- A2A.
ZA200200298B (en) C-Pyrazole A2A receptor agonists.
AU7692896A (en) Quinazolin-2,4-diazirines as NPY receptor antagonist
AU2660399A (en) Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
AU3809999A (en) Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
AU4729699A (en) Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
AU2095099A (en) Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
AU1948601A (en) Triazospiro compounds having nociceptin receptor affinity
AU7132898A (en) Edg-1-like receptor
AU4493496A (en) Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
AU3339697A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU1073501A (en) Histamine receptor
AU3550697A (en) Aminocyclohexane derivatives as 5-ht receptor agonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
AU2001247227A1 (en) 2-thioether a2a receptor agonists
AU2575399A (en) Oxazole derivatives as serotonin-1a receptor agonists
AU4980999A (en) A3 adenosine receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
AU8871898A (en) Phenylindole derivatives as 5-ht2a receptor antagonists
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
AU6230698A (en) Dopamine d4 receptor antagonist
AU3260297A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase